Small, dense low-density lipoprotein particle (sdLDL)

Small, dense low-density lipoprotein particle (sdLDL) is a subclass of LDL particles that are smaller and denser than typical LDL. Unlike large, buoyant LDL particles, sdLDL is more likely to penetrate arterial walls, bind to arterial proteoglycans, undergo oxidation, and contribute to plaque formation (atherogenesis)[3][4]. Elevated levels of sdLDL are strongly associated with increased risk of coronary artery disease and other cardiovascular diseases[4][3][2][6]. SdLDL is not a protein, enzyme, receptor, or gene, but rather a physical particle type defined by its size (approximately 19–25 nm diameter) and density (1.034–1.063 g/ml)[2][4]. It is measured using biochemical techniques such as ultracentrifugation, gradient gel electrophoresis, or nuclear magnetic resonance spectroscopy. Although sdLDL is not directly targeted by drugs, several lipid-lowering therapies—most notably statins—can lower sdLDL levels[3][6]. SdLDL measurement has value in cardiovascular risk stratification, but its use in clinical practice is limited by methodological variability and a lack of evidence that sdLDL-lowering is independently beneficial versus lowering total LDL[3][4].

Other names

Small dense LDLsdLDLSmall dense low-density lipoprotein cholesterol (sdLDL-C)LDL-III and LDL-IV (sometimes used for specific particle size/density classes)

Indirect reduction of sdLDL concentration by lowering overall LDL and modifying lipid metabolism (all above drugs act primarily by lowering total cholesterol, triglycerides, or altering particle size distribution; they do not bind sdLDL directly)[3][6]